NCT00625963

Brief Summary

Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patterns of the PAH disease processes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2007

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2008

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 29, 2008

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
Last Updated

July 30, 2013

Status Verified

July 1, 2013

Enrollment Period

1.2 years

First QC Date

February 20, 2008

Last Update Submit

July 29, 2013

Conditions

Keywords

Pulmonary Hypertension;ILD;CT Imaging;Echocardiogram;Hemodynamic measurements of RHC.Pulmonary Function Tests

Outcome Measures

Primary Outcomes (1)

  • The Study Of CT Scans and Echo Parameters in Patients With PAH

    Correlation of Pulmonary artery diameter as measured by CT scan and Pulmonary artery systolic pressure as measured by Echocardiogram.

    All data has been previously collected.

Study Arms (1)

I,A

I=Pulmonary Hypertension Patients A=ILD patients with Pulmonary Hypertension Patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pulmonary Arterial Hypertension; Idiopathic Lung Disease

You may qualify if:

  • Pulmonary Hypertension;
  • ILD with Pulmonary Hypertension

You may not qualify if:

  • NON-PH

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Shore-Long Island Jewish Health System

New Hyde Park, New York, 11040, United States

Location

MeSH Terms

Conditions

Hypertension, Pulmonary

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Arunabh Talwar, MD

    Northwell Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2008

First Posted

February 29, 2008

Study Start

April 1, 2007

Primary Completion

June 1, 2008

Study Completion

July 1, 2011

Last Updated

July 30, 2013

Record last verified: 2013-07

Locations